In addition, ArthroCare’s sports medicine line grew 6 percent from fourth quarter 2012 to $3.8 million in fourth quarter 2013, including a $1.6 million domestic increase in product sales and a $1.3 million increase in international sales.
For more information on sales, revenues, expenses and growth for ArthroCare’s fourth quarter 2013, view the news release.
More Articles on Devices & Implants:
35 Spine & Orthopedic Devices Receive FDA 501(k) Clearance in January
OMNI Surgical Navigation System Reaches 3k Knee Surgeries
RTI Surgical Reports $60.5M in 4Q Revenue
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
